Jun Yao

17.0k total citations · 3 hit papers
107 papers, 7.5k citations indexed

About

Jun Yao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jun Yao has authored 107 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 30 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Jun Yao's work include Epigenetics and DNA Methylation (12 papers), Cancer Cells and Metastasis (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Jun Yao is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Cancer Cells and Metastasis (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Jun Yao collaborates with scholars based in United States, China and Taiwan. Jun Yao's co-authors include Mien‐Chie Hung, Dihua Yu, Kornélia Polyák, Binhua P. Zhou, Chenfang Dong, Yadi Wu, Ming Tan, Yifan Wang, Kun‐Liang Guan and Min Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Jun Yao

98 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

2013 645 citations Jun Yao, Mien‐Chie Hung et al. profile →
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

2021 405 citations Ri‐Yao Yang, Linlin Sun et al. profile →
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

2021 255 citations Jennifer L. Hsu, Jun Yao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Yao United States	41	4.9k	2.6k	2.2k	1.1k	979	107	7.5k
Anna Dimberg Sweden	38	4.5k 0.9×	2.2k 0.8×	1.5k 0.7×	630 0.6×	1.7k 1.8×	92	7.8k
Paolo Nucíforo Spain	42	4.1k 0.8×	3.4k 1.3×	1.8k 0.8×	699 0.6×	901 0.9×	175	7.3k
Pamela F. Jones United Kingdom	22	7.2k 1.5×	1.6k 0.6×	2.1k 1.0×	757 0.7×	734 0.7×	45	9.5k
Norbert Kraut Austria	33	5.0k 1.0×	2.7k 1.0×	1.4k 0.7×	1.7k 1.6×	635 0.6×	72	7.2k
Toshiyuki Ishiwata Japan	47	3.6k 0.7×	2.5k 1.0×	1.4k 0.7×	935 0.9×	692 0.7×	215	6.4k
Melissa R. Junttila United States	30	3.9k 0.8×	3.0k 1.1×	1.4k 0.7×	524 0.5×	1.4k 1.5×	53	7.1k
Brian Bierie United States	31	4.4k 0.9×	3.6k 1.4×	1.7k 0.8×	569 0.5×	1.2k 1.2×	38	7.1k
Enhua Wang China	37	4.4k 0.9×	1.8k 0.7×	1.3k 0.6×	966 0.9×	703 0.7×	317	6.6k
Alana L. Welm United States	41	4.0k 0.8×	2.4k 0.9×	1.8k 0.8×	494 0.5×	799 0.8×	97	6.5k
Alexei Protopopov United States	41	5.6k 1.1×	1.4k 0.5×	2.1k 1.0×	994 0.9×	744 0.8×	88	8.0k

Countries citing papers authored by Jun Yao

Since Specialization

Citations

This map shows the geographic impact of Jun Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Yao more than expected).

Fields of papers citing papers by Jun Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Yao. The network helps show where Jun Yao may publish in the future.

Co-authorship network of co-authors of Jun Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Yao. A scholar is included among the top collaborators of Jun Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Yao. Jun Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Hai, et al.. (2025). Microscopic flow simulation of acid rock chemical reactions in multi-scale and multi-mineral porous media. Applied Thermal Engineering. 271. 126244–126244. 1 indexed citations

Lin, Shengchao, Yu Zhang, Jun Yao, et al.. (2024). DB-1314, a novel DLL3-targeting ADC with DNA topoisomerase I inhibitor, exhibits promising safety profile and therapeutic efficacy in preclinical small cell lung cancer models. Journal of Translational Medicine. 22(1). 766–766. 9 indexed citations

Yang, Yongfei, et al.. (2024). Pore-scale fluid distribution and remaining oil during tertiary low-salinity waterflooding in a carbonate. Petroleum Science. 21(6). 4130–4140. 7 indexed citations

Shao, Ning, Jun Yao, Pengchao Zhang, et al.. (2023). A Bidirectional Single‐Cell Migration and Retrieval Chip for Quantitative Study of Dendritic Cell Migration. Advanced Science. 10(8). e2204544–e2204544. 9 indexed citations

Wei, Liming, Jun Yao, Xinwen Zhou, et al.. (2023). Elucidation of N-/O-glycosylation and site-specific mapping of sialic acid linkage isomers of SARS-CoV-2 human receptor angiotensin-converting enzyme 2. The Analyst. 148(20). 5002–5011. 1 indexed citations

Liang, Yan, Bo Tu, Jun Yao, et al.. (2021). Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition. Cancer Research. 81(15). 4054–4065. 30 indexed citations

Oh, Hwanhee, Inah Hwang, Lingxiang Wu, et al.. (2021). Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling. Cancer Research. 81(6). 1528–1539. 7 indexed citations

Sun, Linlin, Chia-Wei Li, Ezra M. Chung, et al.. (2020). Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity. Cancer Research. 80(11). 2298–2310. 133 indexed citations

Acharya, Sunil, Jun Yao, Ping Li, et al.. (2019). Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer. Cancer Research. 79(16). 4211–4226. 56 indexed citations

10.

Yao, Jun, Otávia L. Caballero, Ying Huang, et al.. (2016). Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial–Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity. Cancer Immunology Research. 4(6). 552–561. 49 indexed citations

11.

Yoshida, Taku, Jee Hyun Kim, Kristopher Carver, et al.. (2015). CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer. Cancer Research. 75(7). 1516–1526. 84 indexed citations

12.

Wei, Ping, Sicong Zhang, Jun Yao, et al.. (2015). FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells. Cancer Research. 75(11). 2337–2348. 79 indexed citations

13.

Klingler, Stefan, Baofeng Guo, Jun Yao, et al.. (2015). Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms. Cancer Research. 75(10). 2109–2119. 29 indexed citations

14.

Groot, John de, Kathleen R. Lamborn, Susan M. Chang, et al.. (2011). Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study. Journal of Clinical Oncology. 29(19). 2689–2695. 168 indexed citations

15.

Chiu, Wen‐Tai, Hsueh‐Te Lee, Kenneth Aldape, et al.. (2011). Caveolin-1 Upregulation Mediates Suppression of Primary Breast Tumor Growth and Brain Metastases by Stat3 Inhibition. Cancer Research. 71(14). 4932–4943. 55 indexed citations

16.

Neal, Christopher L., Jun Yao, Wentao Yang, et al.. (2009). 14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival. Cancer Research. 69(8). 3425–3432. 158 indexed citations

17.

Kleer, Celina G., Noga Bloushtain-Qimron, Yu‐Hui Chen, et al.. (2008). Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Clinical Cancer Research. 14(17). 5357–5367. 80 indexed citations

18.

Zhao, Xiangshan, Hui Ma, Hongyan Du, et al.. (2008). Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression. Cancer Research. 68(2). 467–475. 36 indexed citations

19.

Nikolsky, Yuri, Jun Yao, Damir Dosymbekov, et al.. (2008). Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer. Cancer Research. 68(22). 9532–9540. 69 indexed citations

20.

Yao, Jun, Stanislawa Weremowicz, Bin Feng, et al.. (2006). Combined cDNA Array Comparative Genomic Hybridization and Serial Analysis of Gene Expression Analysis of Breast Tumor Progression. Cancer Research. 66(8). 4065–4078. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact